Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Total Valuation
Globus Medical has a market cap or net worth of $7.88B. The enterprise value is $7.32B.
Market Cap$7.88B
Enterprise Value$7.32B
Share Statistics
Globus Medical has 112,949,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding112,949,280
Owned by Insiders0.72%
Owned by Institutions36.34%
Financial Efficiency
Globus Medical’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.92%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.92%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee475.35K
Profits Per Employee19.43K
Employee Count5,300
Asset Turnover0.48
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of Globus Medical is 109.01. Globus Medical’s PEG ratio is 1.42.
PE Ratio109.01
PS Ratio0.00
PB Ratio4.04
Price to Fair Value2.69
Price to FCF71.46
Price to Operating Cash Flow41.81
PEG Ratio1.42
Income Statement
In the last 12 months, Globus Medical had revenue of 2.52B and earned 102.98M in profits. Earnings per share was 0.76.
Revenue2.52B
Gross Profit1.48B
Operating Income165.99M
Pretax Income120.72M
Net Income102.98M
EBITDA378.94M
Earnings Per Share (EPS)0.76
Cash Flow
In the last 12 months, operating cash flow was 645.55M and capital expenditures -127.96M, giving a free cash flow of 517.59M billion.
Operating Cash Flow645.55M
Free Cash Flow517.59M
Free Cash Flow per Share4.58
Dividends & Yields
Globus Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change-15.48%
50-Day Moving Average63.65
200-Day Moving Average75.14
Relative Strength Index (RSI)39.73
Average Volume (3m)1.35M
Important Dates
Globus Medical upcoming earnings date is Jul 31, 2025, After Close (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date―
Financial Position
Globus Medical as a current ratio of 2.54, with Debt / Equity ratio of 0.33%
Current Ratio2.54
Quick Ratio1.77
Debt to Market Cap0.04
Net Debt to EBITDA-0.65
Interest Coverage Ratio39.63
Taxes
In the past 12 months, Globus Medical has paid 17.74M in taxes.
Income Tax17.74M
Effective Tax Rate0.15
Enterprise Valuation
Globus Medical EV to EBITDA ratio is 28.97, with an EV/FCF ratio of 27.09.
EV to Sales4.36
EV to EBITDA28.97
EV to Free Cash Flow27.09
EV to Operating Cash Flow21.09
Balance Sheet
Globus Medical has $461.27M in cash and marketable securities with $92.31M in debt, giving a net cash position of -$368.95M billion.
Cash & Marketable Securities$461.27M
Total Debt$92.31M
Net Cash-$368.95M
Net Cash Per Share-$3.27
Tangible Book Value Per Share$14.37
Margins
Gross margin is 74.22%, with operating margin of 6.59%, and net profit margin of 4.09%.
Gross Margin74.22%
Operating Margin6.59%
Pretax Margin4.79%
Net Profit Margin4.09%
EBITDA Margin15.04%
EBIT Margin8.72%
Analyst Forecast
The average price target for Globus Medical is $87.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$87.08
Price Target Upside49.65% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast32.26%
EPS Growth Forecast112.87%